Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jamil Debs
Observed name:
Debs, Jamil
Institution:
Pfizer (United States)
Observed institution:
Pfizer (United States)
OpenAlex ID:
A5042790302
Precision-medicine management recommendations for advanced non-small cell lung cancer: expert consensus
2025
·
Hampig Raphael Kourie
, Mounir Ahmed Bachouchi
, et al.
·
Future Oncology
·
5
Renal cell carcinoma management: real-world practice and challenges at a national level
2023
·
Marwan Ghosn
, Joseph Kattan
, et al.
·
Future Oncology
·
3
Management of breast cancer patients with BRCA gene mutations in Jordan: perspectives and challenges
2023
·
Hikmat Abdel-Razeq
, Salah Abbasi
, et al.
·
Hospital Practice
·
2
PDF
Management of breast cancer patients withBRCAgene mutations in Lebanon of the Middle East: perspectives and challenges
2021
·
Nagi S. El Saghir
, Hady Ghanem
, et al.
·
Hospital Practice
·
1
PDF
Locally advanced/metastatic non-small-cell lung cancer in Lebanon: focus on ALK tyrosine kinase inhibitors
2024
·
Arafat Tfayli
, Hady Ghanem
, et al.
·
Future Oncology
PDF
Management Practices of Locally Advanced and Metastatic Urothelial Carcinoma: A Questionnaire-Based Survey among Lebanese Oncologists
2024
·
Joseph Kattan
, Sally Temraz
, et al.
·
Open Journal of Urology
PDF
Show more works
View as search
Works count:
8
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type